Decision Resources, Inc.

In The News

Manhattan Research Vice President Meredith Ressi and Senior Director Monique Levy quoted in DTC INSIGHTS

March 8, 2010
The number of ePharma Consumers surpassed the 100 million-user mark in 2009, about 44% of U.S. adults, according to Manhattan Research.

Read More
Millennium Research Group data quoted in The Minneapolis Star Tribune

March 7, 2010
Medtronic is seeking regulatory approval for a pacemaker that's compatible with MRIs.

Read More
Millennium Research Group data quoted in blog entry excerpt on Wallet Pop

March 4, 2010
As you read more stories about doctors profiting from the medical devices they use or about noninvasive medical treatments that can be used effectively as alternatives to surgery, you may wonder how you can be fully informed before making a major medical decision.

Read More
Manhattan Research Senior Director Monique Levy quoted in Mobile Enterprise magazine

March 4, 2010
Next time you visit a doctor's office, don't be surprised if she accesses prescription data on her BlackBerry, but don't assume the same technology will be available at your hospital.
Read More
Manhattan Research Senior Director Monique Levy quoted in Medical Marketing & Media magazine

March 4, 2010
About 80% of all US physicians will be using smart phones by 2012, and not just for drug reference or clinical information.
Read More
Millennium Research Group data quoted on the Investor’s Business Daily web site

March 3, 2010
Say you're the CEO of a medtech company with a new technology. You've got FDA approval. Investors like the stock. Up it goes.

Read More
Manhattan Research data quoted on eWEEK.com

March 1, 2010
Nuance introduced a number of mobile solutions for the health care industry, featuring speech-recognition, voice-based search, voice capture and data structuring technologies.

Read More
Article by Millennium Research Group Analyst Nadia Oviedo appeared in Academy News

February 22, 2010
The Asia Pacific Region leads in adoption of immediate functional loading but lags the U.S. and Europe in guided surgery use, according to Millennium Research Group’s 2009 Global Dental Implant report series.

Read More
Manhattan Research Senior Director Monique Levy quoted on American Medical News web site

February 22, 2010
If the launch of the iPad has done anything, it has brought legitimacy to the tablet computer, a product that has long been considered the redheaded stepchild of computing.
Read More
Millennium Research Group Analysts Michelle Li and Dan Whalen quoted on dotmed.com

February 19, 2010
Is China’s mega 850-billion-yuan health care stimulus plan, coupled with a massive population beginning to succumb to Western diseases, a miracle for U.S. medical device makers, or a mirage?

Read More
Manhattan Research Senior Director Erika S. Fishman quoted on American Medical News

February 15, 2010
Girish Munavalli, MD, assistant professor of dermatology at Johns Hopkins University School of Medicine, never considered dermatologists to be all that tech-savvy.
Read More
Millennium Research Group data quoted on The Wall Street Journal

February 11, 2010
It sounds like such a simple concept: Study different medical treatments and figure out which delivers the best results at the cheapest cost, giving patients the most effective care.
Read More
Decision Resources, Inc. Chief Executive Officer Peter Hoenigsberg quoted on Wall Street Letter

February 9, 2010
Decision Resources, a research and advisory firm focused on healthcare insights and analysis, wants to buy small, specialized healthcare boutiques.
Read More
Decision Resources Analyst Matthew Winton, Ph.D. quoted on Bloomberg.com

February 2, 2010
Doctors may learn next month that Dimebon, a 27-year-old hay fever treatment and one of the most mysterious compounds yet tried to fight dementia, is poised to become their newest and perhaps best weapon against Alzheimer’s.

Read More
Millennium Research Group data quoted on The Source

February 1, 2010
With no major economic cycle upturn in sight and a cash hoard on its books, Philips must take decisive action in its healthcare business in the next six months–bullish analysts’ estimates for organic growth notwithstanding.
Read More